182 related articles for article (PubMed ID: 29395313)
1. Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
Zhang HR; Lai SY; Huang LJ; Zhang ZF; Liu J; Zheng SR; Ding K; Bai X; Zhou JY
Gynecol Oncol; 2018 Apr; 149(1):188-197. PubMed ID: 29395313
[TBL] [Abstract][Full Text] [Related]
2. HOXC13 promotes cervical cancer proliferation, invasion and Warburg effect through β-catenin/c-Myc signaling pathway.
Dai M; Song J; Wang L; Zhou K; Shu L
J Bioenerg Biomembr; 2021 Oct; 53(5):597-608. PubMed ID: 34309767
[TBL] [Abstract][Full Text] [Related]
3. Myosin 1b promotes migration, invasion and glycolysis in cervical cancer via ERK/HIF-1α pathway.
Wen LJ; Hu XL; Li CY; Liu J; Li ZY; Li YZ; Zhou JY
Am J Transl Res; 2021; 13(11):12536-12548. PubMed ID: 34956471
[TBL] [Abstract][Full Text] [Related]
4. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
[No Abstract] [Full Text] [Related]
5. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC.
Ohmura G; Tsujikawa T; Yaguchi T; Kawamura N; Mikami S; Sugiyama J; Nakamura K; Kobayashi A; Iwata T; Nakano H; Shimada T; Hisa Y; Kawakami Y
Mol Cancer Res; 2015 Apr; 13(4):721-31. PubMed ID: 25421751
[TBL] [Abstract][Full Text] [Related]
6. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
[TBL] [Abstract][Full Text] [Related]
7. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.
Zeng J; He SL; Li LJ; Wang C
Mol Med; 2021 Oct; 27(1):130. PubMed ID: 34666670
[TBL] [Abstract][Full Text] [Related]
10. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
Pang X; Zhang Y; Zhang S
Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879
[TBL] [Abstract][Full Text] [Related]
11. Wnt-11 overexpression promoting the invasion of cervical cancer cells.
Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang S
Tumour Biol; 2016 Sep; 37(9):11789-11798. PubMed ID: 27034261
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
Chapman BV; Wald AI; Akhtar P; Munko AC; Xu J; Gibson SP; Grandis JR; Ferris RL; Khan SA
BMC Cancer; 2015 Nov; 15():861. PubMed ID: 26545583
[TBL] [Abstract][Full Text] [Related]
15. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
[TBL] [Abstract][Full Text] [Related]
16. The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.
Yu J; Zhang J; Zhou L; Li H; Deng ZQ; Meng B
Med Sci Monit; 2019 Feb; 25():1204-1213. PubMed ID: 30762028
[TBL] [Abstract][Full Text] [Related]
17. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
[TBL] [Abstract][Full Text] [Related]
18. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
19. miR-31 functions as an oncogene in cervical cancer.
Zheng W; Liu Z; Zhang W; Hu X
Arch Gynecol Obstet; 2015 Nov; 292(5):1083-9. PubMed ID: 25894339
[TBL] [Abstract][Full Text] [Related]
20. Role and mechanism of FLNa and UCP2 in the development of cervical cancer.
Wang A; Liu L; Yuan M; Han S; You X; Zhang H; Lei F; Zhang Y
Oncol Rep; 2020 Dec; 44(6):2656-2668. PubMed ID: 33125133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]